Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease

NCT01570764 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis
Scleroderma
Interstitial Lung Disease
Lung Fibrosis

Interventions

DRUG: Cyclophosphamide
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]